Skip to main content

Reader guide

Exosomes: common marketing claims versus the actual evidence

Exosomes are marketed for hair, skin and pain. Here is what has been studied and what remains unresolved.

Published 3 Sept 2026 · Updated 3 Sept 2026

Suitability depends on the condition, cell type, plans permitted under Korean law, and an individual assessment. The EHL team reviews your health information and explains the available options before confirming a care plan.

Exosomes are very small vesicles released by cells, carrying proteins and short nucleic acids, so they are studied as cell-to-cell messengers. Much of the research is laboratory and animal work reporting reduced inflammation and improved tissue repair. In humans there are small studies in hair loss, skin and pain, with preparations so different that results are hard to compare. A core unresolved problem is that exosome quantification and purity have no single agreed standard, so two products under the same name may differ completely. Before deciding, ask: under what manufacturing standard was this made, is there a registered clinical trial, who is accountable if harm occurs, and is there comparison against standard care rather than only before-and-after photos. When the answers are unclear, evidence-based standard treatment is the better value.

Source: PubMed

Related disease topics

Experts behind this content

EHL Thailand Research Desk — Careful reading of study results, including sample size, trial phase and limitations

EHL BIO scientific information is compiled alongside public information from its research team and GMP centre. See the full expert panel

Not sure whether this applies to your case?

Send your questions and initial information through the form. Our team will help prepare your case for an individual assessment with EHL Cell Clinic in Korea.

Consult EHL Thailand